Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|January 11, 2019
A rare population of tumor antigen-specific CD4<sup>+</sup>CD8<sup>+</sup> double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cellsJunko Matsuzaki, Takemasa Tsuji, Thinle Chodon, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2008
Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancerYoshihiro Miyahara, Kunle Odunsi, Wenhao Chen, et al.
Cancer Immunology Research|March 29, 2018
Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell TherapyTakemasa Tsuji, Akira Yoneda, Junko Matsuzaki, et al.
Cancer Immunology Research|April 26, 2014
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cellsJunko Matsuzaki, Takemasa Tsuji, Immanuel Luescher, et al.
Cancer Science|January 31, 2006
1alpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generationJunko Matsuzaki, Takemasa Tsuji, Yue Zhang, et al.
Gynecologic Oncology|April 23, 2016
HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancerJ Brian Szender, Kevin H Eng, Junko Matsuzaki, et al.
Immunology Letters|August 25, 2004
NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivoKenji Chamoto, Tsuguhide Takeshima, Akemi Kosaka, et al.
Cancer Research|July 17, 2012
CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunityNassima Redjimi, Caroline Raffin, Isabelle Raimbaud, et al.
International Journal of Molecular Sciences|April 11, 2020
Sublethal Radiation Affects Antigen Processing and Presentation Genes to Enhance Immunogenicity of Cancer CellsAchamaporn Punnanitinont, Eric D Kannisto, Junko Matsuzaki, et al.
Plos One|August 23, 2011
Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donorsTakemasa Tsuji, Junko Matsuzaki, Erika Ritter, et al.
Pageof 9